Mark E. McCabe

Mark McCabe practices at Allergy Partners of East Texas in Tyler, Texas.

Mark McCabe's NPI, 1396107371, was assigned on March 28, 2016. Mark McCabe graduated from UTMB Health in 2016. Mark McCabe holds Texas license T0858.

Mark McCabe's primary practice is Allergy Partners of East Texas, at 1128 Medical Dr, Tyler, TX 75701 in Smith County. The practice phone is (903) 593-8273.

Mark McCabe's primary practice is Allergy Partners of East Texas in Tyler, Texas. The medical group on file is Allergy Partners of Corpus Christi. Dmand AI also links Mark McCabe to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark McCabe practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Mark McCabe's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Mark McCabe is board certified in allergy & immunology by the American Board of Allergy and Immunology. Mark McCabe is licensed in Texas.

Dmand AI lists asthma, chronic nasal allergies and hives among the conditions Mark McCabe treats.

CMS data shows 11,793 Medicare services from Mark McCabe across 12 procedure codes in 2024, for 329 Medicare patients. Medicare paid $99,428 for them. Every service was in an office.

CMS counts 329 Medicare patients who saw Mark McCabe in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mark McCabe's median patient age at 40, with 58% women.

In 2024, Mark McCabe wrote 851 Medicare Part D claims for 275 patients. 67% of them were for generic drugs. CMS names the drug for 760 of them, across 19 drugs with 11 or more claims each, at $159,138 in total drug cost. In 2023, CMS named 336 claims across 9 drugs.

Mark McCabe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Mark McCabe in 2021. 2021 was the busiest year, with 2. Mark McCabe's most frequent co-authors are Julia Woodard Tripple, MD and Jennifer McCracken, MD.

CMS Open Payments shows 158 general payments to Mark McCabe from 22 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 82% of the total. Sanofi and Genzyme US Companies paid the most, $1,025.

Mark McCabe graduated from UTMB Health in 2016.

Mark McCabe is in network with 23 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.